인쇄하기
취소

Hemophila patients call for lifting age restriction over insurance of Kogenate FS

Published: 2010-11-26 06:56:00
Updated: 2010-11-26 06:56:00
Will hemophila patients be able to get cheaper and better drugs this year?

Now all eyes are on the Ministry for Health, Welfare and Family Affair's decision on the insurance price of Kogenate FS, a new drug for the disease. Kogenate, antihemophilic factor (recombinant) is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative man...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.